SC
ACHV icon

Searle & Co’s Achieve Life Sciences ACHV Stock Holding History

Searle & Co’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,655
Closed -$45K – 140
2020
Q2 		$45K Hold
5,655
– – 0.03% 134
2020
Q1 		$37K Hold
5,655
– – 0.03% 128
2019
Q4 		$60K Sell
5,655
-975
-15% -$20.9K 0.03% 133
2019
Q3 		$225K Hold
6,630
– – 0.13% 122
2019
Q2 		$256K Buy
6,630
+2,955
+80% +$209K 0.16% 111
2019
Q1 		$237K Buy
+3,675
New +$148K 0.15% 116

Other funds holding ACHV

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HR
Hayden Royal Charlotte, North Carolina $42.7M AUM 33.86% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Searle & Co's ACHV Position: Q3 2020 in Review

Searle & Co sold out of Achieve Life Sciences (ACHV) in Q3 2020, closing a stake of 5,655 shares — an estimated $45K sold.

Searle & Co first reported a position in ACHV in Q1 2019 and held it in 6 quarters. The position peaked at $256K in Q2 2019. 13 funds tracked by Wall St. Rank hold ACHV as of Q3 2020.

  • Searle & Co reported no remaining Achieve Life Sciences position as of Q3 2020 after selling out during the quarter.
  • Searle & Co sold 5,655 Achieve Life Sciences shares in Q3 2020, an estimated $45K.
  • Searle & Co first reported a position in Achieve Life Sciences in Q1 2019 and held it in 6 quarters.
  • Searle & Co's Achieve Life Sciences position peaked at $256K in Q2 2019.
  • 13 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2020.

Based on Searle & Co's 13F filing for Q3 2020, filed 30 Oct 2020.